Valuation : 3SBio Inc.

Market Cap 36.66B 42.74B 5.45B 4.68B 4.39B 4.01B 7.57B 520B 7.61B 51.98B 20.15B 262B 20.47B 20.03B 869B P/E 2026 *
15.5x
P/E 2027 * 14x
Enterprise Value 26.53B 30.93B 3.95B 3.39B 3.18B 2.9B 5.48B 376B 5.5B 37.61B 14.58B 190B 14.81B 14.49B 629B EV / Sales 2026 *
2.82x
EV / Sales 2027 * 2.24x
Free-Float
74.93%
Yield 2026 *
1.39%
Yield 2027 * 1.75%
1 day-2.17%
1 week+2.76%
Current month+2.57%
1 month-0.75%
3 months-6.08%
6 months-19.93%
Current year-29.07%
1 week 16.2
Extreme 16.2
18.65
1 month 16.16
Extreme 16.16
18.96
Current year 14.81
Extreme 14.81
29.3
1 year 14.81
Extreme 14.81
36.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO 43 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Date Insider Type Main position Quantity % Market Cap.
7/29/25 A Other

Chief Executive Officer

440,000 0.0184%
4/15/25 A Other

Director

26,000 0.0011%
4/11/25 A Other

Director

460,000 0.0192%
Change 5-day change 1-year change 3-year change Capi.($)
-2.17%+2.76%-43.02%+156.74% 5.57B
-0.08%-1.39%+38.88%-1.89% 81.36B
-7.06%+4.13%+453.07%+21.95% 59.75B
+0.84%+4.44%-19.19%-35.11% 59.19B
+0.76%+3.53%+0.08%+36.18% 53.33B
+0.41%+1.84%+10.29%+170.02% 49.09B
+0.15%+3.35%+62.47%-16.42% 32.66B
-0.28%+0.30%+50.41%+96.83% 25.97B
-2.00%+9.52%+12.38%+218.34% 24.39B
+0.78%+0.47%+61.53%+123.40% 16.91B
Average -0.85%+0.64%+62.69%+77.00% 40.82B
Weighted average by Cap. -0.88%-0.93%+83.44%+48.06%

Financials

2026 *2027 *
Net sales 9.41B 10.97B 1.4B 1.2B 1.13B 1.03B 1.94B 134B 1.95B 13.34B 5.17B 67.35B 5.26B 5.14B 223B 10.1B 11.77B 1.5B 1.29B 1.21B 1.1B 2.09B 143B 2.1B 14.32B 5.55B 72.25B 5.64B 5.52B 239B
Net income 2.35B 2.74B 349M 300M 281M 257M 485M 33.32B 487M 3.33B 1.29B 16.81B 1.31B 1.28B 55.67B 2.69B 3.14B 400M 344M 323M 295M 556M 38.18B 559M 3.82B 1.48B 19.26B 1.5B 1.47B 63.8B
Net Debt -10.13B -11.81B -1.51B -1.29B -1.21B -1.11B -2.09B -144B -2.1B -14.37B -5.57B -72.52B -5.66B -5.54B -240B -14.05B -16.38B -2.09B -1.79B -1.68B -1.54B -2.9B -199B -2.92B -19.93B -7.72B -101B -7.85B -7.68B -333B
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,068
Date Price Change Volume
27/08/26 HK$17.15 -2.17% 27,655,804
26/08/26 HK$17.53 -0.74% 25,257,200
25/08/26 HK$17.66 -1.34% 21,974,580
24/08/26 HK$17.90 +0.39% 29,610,102
21/08/26 HK$17.83 +8.06% 71,334,193
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
15.04CNY
Average target price
26.90CNY
Spread / Average Target
+78.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1530 Stock